| Cerebral palsy and the application of the international criteria for acute intrapartum hypoxia EMM Strijbis, I Oudman, P Van Essen, AH MacLennan Obstetrics & Gynecology 107 (6), 1357-1365, 2006 | 170 | 2006 |
| Natalizumab drug holiday in multiple sclerosis: poorly tolerated J Killestein, A Vennegoor, EM Strijbis, A Seewann, BW van Oosten, ... Annals of neurology 68 (3), 392-395, 2010 | 157 | 2010 |
| Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis A Vennegoor, T Rispens, EMM Strijbis, A Seewann, BMJ Uitdehaag, ... Multiple Sclerosis Journal 19 (5), 593-600, 2013 | 144 | 2013 |
| Cortical remyelination is heterogeneous in multiple sclerosis EMM Strijbis, EJ Kooi, P van der Valk, JJG Geurts Journal of Neuropatholgy & Experimental Neurology 76 (5), 390-401, 2017 | 80 | 2017 |
| Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications EJ Kooi, EMM Strijbis, P van der Valk, JJG Geurts Neurology 79 (13), 1369-1376, 2012 | 68 | 2012 |
| Performance of the 2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study M Filippi, P Preziosa, A Meani, G Dalla Costa, S Mesaros, J Drulovic, ... Neurology 98 (1), e1-e14, 2022 | 54 | 2022 |
| Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic ZYGJ van Lierop, AA Toorop, WJC van Ballegoij, TBG Olde Dubbelink, ... Multiple Sclerosis Journal 28 (7), 1121-1125, 2022 | 48 | 2022 |
| SARS-CoV-2 antibodies in adult patients with multiple sclerosis in the Amsterdam MS cohort ZLE Van Kempen, EMM Strijbis, MMCT Al, M Steenhuis, BMJ Uitdehaag, ... JAMA neurology 78 (7), 880-882, 2021 | 47 | 2021 |
| Histone deacetylase gene variants predict brain volume changes in multiple sclerosis B Inkster, EMM Strijbis, M Vounou, L Kappos, EW Radue, PM Matthews, ... Neurobiology of aging 34 (1), 238-247, 2013 | 37 | 2013 |
| The physiological variation of the retinal nerve fiber layer thickness and macular volume in humans as assessed by spectral domain–optical coherence tomography LJ Balk, JM Sonder, EMM Strijbis, JWR Twisk, J Killestein, BMJ Uitdehaag, ... Investigative ophthalmology & visual science 53 (3), 1251-1257, 2012 | 36 | 2012 |
| Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination S Ghorbani, E Jelinek, R Jain, B Buehner, C Li, BM Lozinski, S Sarkar, ... Nature communications 13 (1), 2445, 2022 | 31 | 2022 |
| Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS DN Schoonhoven, M Fraschini, P Tewarie, BMJ Uitdehaag, AJC Eijlers, ... Multiple Sclerosis Journal 25 (14), 1896-1906, 2019 | 27 | 2019 |
| Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology E Oudejans, A Luchicchi, EMM Strijbis, JJG Geurts, AM van Dam Neurology: Neuroimmunology & Neuroinflammation 8 (1), e914, 2020 | 26 | 2020 |
| Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: to wait and repopulate? ZLE van Kempen, L Wieske, EW Stalman, LYL Kummer, PJ van Dam, ... Multiple sclerosis and related disorders 57, 103416, 2022 | 25 | 2022 |
| Glutamate gene polymorphisms predict brain volumes in multiple sclerosis EMM Strijbis, B Inkster, M Vounou, Y Naegelin, L Kappos, EW Radue, ... Multiple Sclerosis Journal 19 (3), 281-288, 2013 | 25 | 2013 |
| Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab AA Toorop, ZYG van Lierop, EEM Strijbis, CE Teunissen, A Petzold, ... Neurology: Neuroimmunology & Neuroinflammation 8 (1), e904, 2020 | 23 | 2020 |
| Association of age with contrast-enhancing lesions across the multiple sclerosis disease spectrum MW Koch, J Mostert, Y Zhang, JS Wolinsky, FD Lublin, E Strijbis, G Cutter Neurology 97 (13), e1334-e1342, 2021 | 20 | 2021 |
| Blood platelet RNA enables the detection of multiple sclerosis N Sol, CE Leurs, SGJGI Veld, EM Strijbis, A Vancura, MW Schweiger, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 6 (3 …, 2020 | 20 | 2020 |
| Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study M Margoni, E Pagani, A Meani, L Storelli, S Mesaros, J Drulovic, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (7), 741-752, 2022 | 17 | 2022 |
| Longitudinal changes in cognitive test scores in patients with relapsing-remitting multiple sclerosis: an analysis of the DECIDE dataset N Castrogiovanni, J Mostert, P Repovic, JD Bowen, BMJ Uitdehaag, ... Neurology 101 (1), e1-e11, 2023 | 16 | 2023 |
